Stay updated on Inhibitors for COVID-19 Clinical Trial
Sign up to get notified when there's something new on the Inhibitors for COVID-19 Clinical Trial page.

Latest updates to the Inhibitors for COVID-19 Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedAdministrative update: revision v3.3.4 was added and v3.3.3 was removed, with no impact on study content or user-facing functionality. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check16 days agoNo Change Detected
- Check30 days agoChange DetectedRevision: v3.3.3 was added. HHS Vulnerability Disclosure and Revision: v3.3.2 were removed.SummaryDifference0.1%

- Check59 days agoChange DetectedAdded explicit study-site details (five locations: Leeds; London—two sites; Reading; Sheffield) with the associated NHS Trusts. Clarified the primary outcome definitions for MATIS and linked related study documents (Protocol, SAP) and data-sharing information.SummaryDifference7%

- Check66 days agoChange DetectedThe government funding/operating status notice banner has been removed from the page; it previously informed users that information may not be up to date and pointed to operating status resources. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check80 days agoChange DetectedMinor wording and formatting updates appear in the Study Overview and Contacts/Locations sections; core trial content such as eligibility criteria, treatment arms, and primary outcomes remains unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check108 days agoChange Detected- Removed version v3.1.0 and added notice about government funding lapse and current NIH Clinical Center status with links, plus new version tag v3.2.0. Overall, the page now communicates current operating status and a newer version rather than the old one.SummaryDifference3%

Stay in the know with updates to Inhibitors for COVID-19 Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Inhibitors for COVID-19 Clinical Trial page.